A citation-based method for searching scientific literature

D L Browne, S T Gancher, J G Nutt, E R Brunt, E A Smith, P Kramer, M Litt. Nat Genet 1994
Times Cited: 577



Lily Yeh Jan, Yuh Nung Jan. J Physiol 2012
Times Cited: 124




List of shared articles



Times cited

Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
Rían W Manville, Geoffrey W Abbott. J Pharmacol Exp Ther 2020
6

Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.
Kelsey Paulhus, Lauren Ammerman, Edward Glasscock. Int J Mol Sci 2020
15


Genetic ablation or pharmacological inhibition of Kv1.1 potassium channel subunits impairs atrial repolarization in mice.
Man Si, Krystle Trosclair, Kathryn A Hamilton, Edward Glasscock. Am J Physiol Cell Physiol 2019
8

Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.
Julia Oyrer, Snezana Maljevic, Ingrid E Scheffer, Samuel F Berkovic, Steven Petrou, Christopher A Reid. Pharmacol Rev 2018
75

Purkinje Cell Signaling Deficits in Animal Models of Ataxia.
Eriola Hoxha, Ilaria Balbo, Maria Concetta Miniaci, Filippo Tempia. Front Synaptic Neurosci 2018
34

Scn2a deletion improves survival and brain-heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP).
Vikas Mishra, Bharat K Karumuri, Nicole M Gautier, Rui Liu, Timothy N Hutson, Stephanie L Vanhoof-Villalba, Ioannis Vlachos, Leonidas Iasemidis, Edward Glasscock. Hum Mol Genet 2017
27

Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway.
Barbara Fellerhoff-Losch, Sergiy V Korol, Yonatan Ganor, Songhai Gu, Itzik Cooper, Raya Eilam, Michal Besser, Meidan Goldfinger, Yehuda Chowers, Rudolf Wank,[...]. J Neural Transm (Vienna) 2016
2

Distinctive role of KV1.1 subunit in the biology and functions of low threshold K(+) channels with implications for neurological disease.
Saak V Ovsepian, Marie LeBerre, Volker Steuber, Valerie B O'Leary, Christian Leibold, J Oliver Dolly. Pharmacol Ther 2016
29

Action potential broadening in a presynaptic channelopathy.
Rahima Begum, Yamina Bakiri, Kirill E Volynski, Dimitri M Kullmann. Nat Commun 2016
35

Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
Mark A Corbett, Susannah T Bellows, Melody Li, Renée Carroll, Silvana Micallef, Gemma L Carvill, Candace T Myers, Katherine B Howell, Snezana Maljevic, Holger Lerche,[...]. Neurology 2016
41

De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
Steffen Syrbe, Ulrike B S Hedrich, Erik Riesch, Tania Djémié, Stephan Müller, Rikke S Møller, Bridget Maher, Laura Hernandez-Hernandez, Matthis Synofzik, Hande S Caglayan,[...]. Nat Genet 2015
142